Satellos Bioscience Inc
TSX:MSCL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Satellos Bioscience Inc
TSX:MSCL
|
CA |
|
Clinica Baviera SA
MAD:CBAV
|
ES |
|
Phoslock Environmental Technologies Ltd
ASX:PET
|
AU |
|
Dominion Energy Inc
NYSE:D
|
US |
|
G
|
Get Nice Holdings Ltd
HKEX:64
|
HK |
|
Caisse Regionale de Credit Agricole Mutuel Atlantique Vendee SC
PAR:CRAV
|
FR |
|
N
|
Nikon Corp
XMUN:NKN
|
JP |
|
R
|
RE Royalties Ltd
OTC:RROYF
|
CA |
|
T
|
TotalEnergies SE
SWB:TOTB
|
FR |
|
Clever Leaves Holdings Inc
OTC:CLVR
|
CO |
|
Banco Bilbao Vizcaya Argentaria SA
MIL:1BBVA
|
ES |
|
S
|
Sompo Holdings Inc
XMUN:ANK
|
JP |
|
B
|
Benefit Systems SA
WSE:BFT
|
PL |
|
Primary Health Properties PLC
LSE:PHP
|
UK |
|
S
|
Sumitomo Realty & Development Co Ltd
F:RL2
|
JP |
|
A
|
Adler Group SA
DUS:ADJ
|
LU |
|
A
|
Acura Pharmaceuticals Inc
OTC:ACUR
|
US |
|
Clorox Co
NYSE:CLX
|
US |
Bankruptcy Probability
Satellos Bioscience Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Satellos Bioscience Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Satellos Bioscience Inc
TSX:MSCL
|
268.2m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
467.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
212.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
186.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
129.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
69B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
53.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Satellos Bioscience Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Satellos Bioscience Inc has no debt.
You can find a full breakdown on its Balance Sheet.